Steroids in the treatment of smoke inhalation injury

Journal of Burn Care and Research

Volumn 30, Issue 1, 2009, Pages 165-169

  Greenhalgh, David G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHLOROFLUOROCARBON; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; LEUKOTRIENE; METHYLPREDNISOLONE; MONTELUKAST; PLACEBO; SALBUTAMOL; SALMETEROL; STEROID; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; ZAFIRLUKAST;

ADRENAL CORTEX INSUFFICIENCY; ADULT RESPIRATORY DISTRESS SYNDROME; ASTHMA; BEDTIME DOSAGE; BRONCHOSPASM; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; COUGHING; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG USE; DRY POWDER; DYSPHONIA; GROWTH RATE; HUMAN; INHALER; LOW DRUG DOSE; LUNG BURN; LUNG FUNCTION; MORTALITY; OROPHARYNX CANDIDIASIS; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYSTEMIC THERAPY; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 59449098609     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3181923c08     Document Type: Conference Paper

References (27)

1. Palmieri TL, Enkhbaatar P, Bayliss R, et al. Continuous nebulized albuterol attenuates acute lung injury in an ovine model of combined burn and smoke inhalation. Crit Care Med 2006;34:1719-24.
2. Roland NJ, Bhalla RK, Earis J. The local side effects of inhaled corticosteroids. Current understanding and review of the literature. Chest 2004;126:213-6.
3. Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respiratory Med 2006;100:1307-17.
4. Denlinger LC, Sorkness CA, Chinchilli VM, Lemanske RF Jr. Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network. J Allergy Clin Immunol 2007;119:3-11.
5. Drazen JM, Israel E, Boushey HA, et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 1996;335:841-7.
6. Pearlman DS, Chervinsky P, LaForce C, et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992;327:1420-5.
7. Lemanske RF Jr, Sorkness CA, Mauger EA, et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA 2001;285:2594-603.
8. Israel E, Chinchilli VM, Ford JG, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004;364:1505-12.
9. Wechsler ME, Lehman E, Lazarus SC, et al. Beta-adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 2006;173:519-23.
10. Martin RJ, Szefler SJ, Chinchilli VM, et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 2002;165:1377-83.
11. Szefler SJ, Martin RJ, King TS, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002;109:410-8.
12. Boushey HA, Sorkness CA, KingTS, et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005;352:1519-28.
13. American Lung Association Asthma Clinical Research Centers, Peters SP, Anthonisen N, et al. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 2007;356:2027-39.
14. Papi A, Canonica GW, Maestrelli P, et al. Rescue use of be-clomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007;356:2040-52.
15. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006;354:1985-97.
16. Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005;115: 233-42.
17. Sorkness CA, Lemanske RF Jr, Mauger DR, et al. Long-term comparison of 3 controller regimens for mild-moderatepersistentasthma: thePediatric Asthma Controller Trial. J Allergy Clin Immunol 2007;119:60-8.
18. Bernard GB, Luuce JM, Sprung CL. High dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987;317:1565-70.
19. Agarwal R, Nath A, Aggarwal AN, Gupta D. Do glucocorticoids decrease mortality in acute respiratory distress syndrome? A meta-analysis. Respirology 2007;12:585-90.
20. Meduri GU, Yates CR. Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS. Ann N Y Acad Sci 2004;1024:24-53.
21. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS. Results of a randomized controlled trial. Chest 2007;131:954-63.
22. Moylan JA, Alexander LG Jr. Diagnosis and treatment of inhalation injury. World J Surg 1978;2:185-91.
23. Levine BA, Petroff PA, Slade CL, Pruitt BA Jr. Prospective trials of dexamethasone and aerosolized gentamicin in the treatment of inhalation injury in the burned patient. J Trauma 1978;18:188-93.
24. Robinson NB, Hudson LD, Riem M, et al. Steroid therapy following isolated smoke inhalation injury. J Trauma 1982; 22:876-9.
25. Cha SI, Kim CH, Lee JH, et al. Isolated smoke inhalation injuries: acute respiratory dysfunction, clinical outcomes, and short-term evolution of pulmonary functions with the effects of steroids. Burns 2007;33:200-8.
26. Nieman GF, Clark WF, Hakim T. Methylprednisolone does not protect the lung from inhalation injury. Burns 1991;17: 384-90.
27. Wang S, Lantz RC, Robledo RF, et al. Early alterations of lung injury following acute smoke exposure and 21- aminosteroid treatment. Toxicol Pathol 1999;27:334-41.